Results 21 to 30 of about 6,717 (218)

Hydrogen Sulfide Deficiency Contributes to Tubular Damage and Calcium Oxalate Crystal Formation in Hyperoxaluria Nephropathy: Role of Osteopontin and Tamm–Horsfall Protein [PDF]

open access: yesAntioxidants
Hydrogen sulfide (H2S) exerts regulatory functions in kidney diseases. However, its protective role against kidney stone formation remains unclear. Here, we demonstrate that hyperoxaluria or oxalate exposure impairs H2S formation, leading to tubular ...
Chien-Lin Lu   +4 more
doaj   +2 more sources

The Long Pentraxin PTX3 Is an Endogenous Inhibitor of Hyperoxaluria-Related Nephrocalcinosis and Chronic Kidney Disease [PDF]

open access: yesFrontiers in Immunology, 2018
The long pentraxin 3 (PTX3) exerts a variety of regulatory functions in acute and chronic tissue inflammation. In particular, PTX3 acts as an opsonin for a variety of pathogens and endogenous particles.
Julian A. Marschner   +13 more
doaj   +2 more sources

Homozygous GRHPR C.494G>A mutation is deleterious that causes early onset of nephrolithiasis in West Bengal, India

open access: yesFrontiers in Molecular Biosciences, 2022
Pediatric nephrolithiasis (NL) or Kidney stone disease (KSD) is an untethered topic in Asian population. In Western countries, the annual incidence of paediatric NL is around 6–10%.
Arindam Chatterjee   +14 more
doaj   +1 more source

The Primary Hyperoxalurias [PDF]

open access: yesJournal of the American Society of Nephrology, 2001
The primary hyperoxalurias (PHs) are rare disorders of glyoxylate metabolism in which specific hepatic enzyme deficiencies result in overproduction of oxalate. Due to the resulting severe hyperoxaluria, recurrent urolithiasis or progressive nephrocalcinosis are principal manifestations.
M, Marangella   +6 more
openaire   +4 more sources

Primary Hyperoxaluria Type 1: The First Patient Treated with Lumasiran in Portugal

open access: yesRevista Portuguesa de Nefrologia e Hipertensão, 2023
Primary hyperoxaluria type 1 is a rare genetic disease caused by mutations in AGXT, leading to an excessive hepatic production of oxalate, resulting in urolithiasis, nephrocalcinosis and chronic kidney disease.
Madalena Almeida Borges   +5 more
doaj   +1 more source

Postbiotics and Kidney Disease

open access: yesToxins, 2022
Chronic kidney disease (CKD) is projected to become the fifth global cause of death by 2040 as a result of key shortcomings in the current methods available to diagnose and treat kidney diseases.
Chiara Favero   +5 more
doaj   +1 more source

Long-term outcome after combined or sequential liver and kidney transplantation in children with infantile and juvenile primary hyperoxaluria type 1

open access: yesFrontiers in Pediatrics, 2023
IntroductionCombined or sequential liver and kidney transplantation (CLKT/SLKT) restores kidney function and corrects the underlying metabolic defect in children with end-stage kidney disease in primary hyperoxaluria type 1 (PH1).
Sebastian Loos   +12 more
doaj   +1 more source

Current update and future directions on gut microbiome and nephrolithiasis

open access: yesIndian Journal of Urology, 2020
The incidence of nephrolithiasis is increasing worldwide. Understanding how gut microbiome influences oxalate homeostasis has the potential to offer new strategies to prevent nephrolithiasis.
Ajay P Sharma   +3 more
doaj   +1 more source

Primary Hyperoxaluria [PDF]

open access: yesInternational Journal of Nephrology, 2011
Primary hyperoxalurias (PH) are inborn errors in the metabolism of glyoxylate and oxalate. PH type 1, the most common form, is an autosomal recessive disorder caused by a deficiency of the liver-specific enzyme alanine, glyoxylate aminotransferase (AGT) resulting in overproduction and excessive urinary excretion of oxalate.
Jérôme Harambat   +4 more
openaire   +3 more sources

Cardiac involvement of primary hyperoxaluria accompanied by non-compaction cardiomyopathy and patent ductus arteriosus

open access: yesTürk Kardiyoloji Derneği Arşivi, 2015
Primary hyperoxaluria is a rare hereditary metabolic disorder resulting in accumulation of calcium oxalate in visceral organs, including the heart. We report a 19-year-old male with non- compaction cardiomyopathy combined with patent ductus arteriosus ...
Nurcan Arat   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy